AstraZeneca challenges Axelpharm’s cancer drug patent
AstraZeneca is a world-renowned pharmaceutical company. It owns many patents in Russia and takes steps to protect them against encroachers. Its medicines are exempt from sanctions because they are mainly used for the life-preserving treatment of cancer. Axelpharm, a...
USPTO issues final rule on Director Review of PTAB decisions
On October 1, 2024, the USPTO published a new final rule, Rules Governing Director Review of Patent Trial and Appeal Board (PTAB) Decisions. 89 Fed. Reg. 79,744 (October 1, 2024). The final rule codifies many aspects of the PTAB’s revised interim Director Review...
UK IPO campaign highlights dangers of counterfeit vehicle parts
The campaign focuses on the serious risks these goods pose, warning that ‘Fake Always Breaks’ The UK Intellectual Property Office (UKIPO) has launched a new national awareness campaign warning of the dangers of buying counterfeit vehicle parts The ‘Fake Always...
The dark side of fake goods: consumers put health, safety, and the economy at risk while fuelling organized crime
Organized crime groups take advantage of worldwide demand for low-priced goods, misleading consumers into purchasing fake goods Approximately 86 million fake items were seized in the EU in 2022, with an estimated value exceeding €2 billion Counterfeit goods represent...
Welcome to Hangzhou! The AIPPI World Congress 2024
AIPPI World Congress 2024 opened its doors in Hangzhou, China, on Saturday, 19 October. All attending were warmly welcomed, and there was general excitement for the next few days of educational sessions, member meetings, and networking. Guoqing ZHANG, Vice Premier of...
‘Squeeze argument’ in patent infringement: tamper-evident closure case
A recent judgment on 8 May 2024, by the Hon'ble High Court of Delhi, in Guala Closures SPA v. AGI Greenpac Limited sheds light on the strategic maneuver known as the 'squeeze argument' and its profound significance in patent infringement cases. This case underscores...
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
The license agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering. Dublin, Ireland, and Rome, Italy, 20 May 2024 — ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and IRBM, a leader in...
UPC referendum in Ireland postponed
The Irish Government has confirmed its decision to defer the date for the referendum for the ratification of the agreement on a Unified Patent Court (UPC), which was due to be held on 7 June 2024 to coincide with the European and Local elections. No alternative date...
Neuroscience nugget for Mental Health Awareness Week: moving with awareness
We all know that being active is important for our physical and mental health. However, I am going to look beyond the obvious benefits of being active and take a deeper dive into the field of neuroscience, which demonstrates the interconnectedness of our mind and body...
16th edition of Global IP Convention, Istanbul: India’s flagship event is now in Turkey
The Global Intellectual Property Conference (GIPC) is where brilliance meets influence. This isn't your average gathering; it's a convergence of thought leaders, industry titans, innovators, legal experts, and executives from Fortune 500 companies. Step into the...
Number of drone patents filed worldwide jumps 16% in past year
R&D in defense driving innovation in drone technology, alongside agriculture and logistics Russia filing significant number of patents as drones used in conflict AI is also a key part of the increase in drone patent filings. The number of global patents filed for...
EUIPO’s 5th IP Case Law Conference: an inside look
We were delighted to attend the EUIPO’s 5th IP Case Law Conference held in Alicante on the 29-30 of April 2024 – special thanks to EUIPO for the invitation and exceptional hospitality throughout the conference. Following a warm welcome from Master of Ceremony Thomas...
Legal dispute redefining COVID-19 vaccine patents and future of mRNA tech
The race for a COVID-19 vaccine in 2020 was a global effort, but the aftermath has seen a bitter legal battle erupt between pharmaceutical giants. In August 2022, Moderna, a pioneer in messenger RNA (mRNA) technology, launched a lawsuit against Pfizer and BioNTech,...
Delhi High Court awards Ericsson $29 million in SEP case
On 28 March 2024, the Delhi High Court concluded a decade-long litigation between Telefonaktiebolaget LM Ericsson (Ericsson) and Lava Intl. Ltd (Lava) by delivering a landmark judgment that Lava infringed Ericsson’s eight Standard Essential Patents (SEPs) relating to...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.